These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 32766134)

  • 21. Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on
    Huang Y; Jiang X; Xu H; Zhang D; Liu LN; Xia YX; Xu DK; Wu HJ; Cheng G; Shi YH
    Clin Radiol; 2023 Jan; 78(1):8-17. PubMed ID: 36192203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
    Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
    Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
    Front Oncol; 2022; 12():894323. PubMed ID: 35800046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A
    Wang B; Hu T; Shen R; Liu L; Qiao J; Zhang R; Zhang Z
    Abdom Radiol (NY); 2024 Aug; ():. PubMed ID: 39096393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomics Features of
    Kang J; Lee JH; Lee HS; Cho ES; Park EJ; Baik SH; Lee KY; Park C; Yeu Y; Clemenceau JR; Park S; Xu H; Hong C; Hwang TH
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33494345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Validation of an
    Huang J; Li T; Tang L; Hu Y; Hu Y; Gu Y
    Acad Radiol; 2024 Dec; 31(12):5066-5077. PubMed ID: 38845294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computer Tomography Radiomics-Based Nomogram in the Survival Prediction for Brain Metastases From Non-Small Cell Lung Cancer Underwent Whole Brain Radiotherapy.
    Zhang J; Jin J; Ai Y; Zhu K; Xiao C; Xie C; Jin X
    Front Oncol; 2020; 10():610691. PubMed ID: 33643912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.
    Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J
    Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An
    Feng L; Lu X; Yang X; Kan Y; Sun D; Wang W; Yang J
    Eur J Radiol; 2022 Sep; 154():110444. PubMed ID: 35917754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomics Analysis of PET and CT Components of
    Wang X; Lu Z
    Front Oncol; 2021; 11():638124. PubMed ID: 33928029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
    Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
    Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage-Specific PET Radiomic Prediction Model for the Histological Subtype Classification of Non-Small-Cell Lung Cancer.
    Ji Y; Qiu Q; Fu J; Cui K; Chen X; Xing L; Sun X
    Cancer Manag Res; 2021; 13():307-317. PubMed ID: 33469373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Approach Using FDG-PET/CT-Based Radiomics to Assess Tumor Immune Phenotypes in Patients With Non-Small Cell Lung Cancer.
    Zhou J; Zou S; Kuang D; Yan J; Zhao J; Zhu X
    Front Oncol; 2021; 11():769272. PubMed ID: 34868999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomics-clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma.
    Ding J; Li Z; Lin Y; Huang C; Chen J; Hong J; Fei Z; Zhou Q; Chen C
    Sci Rep; 2023 Oct; 13(1):18167. PubMed ID: 37875498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiomics of
    Mu W; Tunali I; Gray JE; Qi J; Schabath MB; Gillies RJ
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1168-1182. PubMed ID: 31807885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of
    Shao X; Niu R; Shao X; Jiang Z; Wang Y
    EJNMMI Res; 2020 Jul; 10(1):80. PubMed ID: 32661639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of an [
    Takahashi N; Tanaka S; Umezawa R; Takanami K; Takeda K; Yamamoto T; Suzuki Y; Katsuta Y; Kadoya N; Jingu K
    Acta Oncol; 2023 Feb; 62(2):159-165. PubMed ID: 36794365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic nomogram combining
    Zhang Y; Cui Y; Liu H; Chang C; Yin Y; Wang R
    Sci Rep; 2024 Sep; 14(1):20557. PubMed ID: 39231973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
    Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
    EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Value of
    Feng L; Yang X; Lu X; Kan Y; Wang C; Zhang H; Wang W; Yang J
    Acad Radiol; 2023 May; 30(5):940-951. PubMed ID: 36117128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.